High-Grade Malignant Glioma: ESMO Clinical Practice Guidelines

Published in 2014 Ann Oncol (2014) 25 (suppl 3): iii93-iii101.
Authors: R. Stupp, M. Brada, M. J. van den Bent, J.-C. Tonn, G. Pentheroudakis

This update covers recommendations for glioblastoma; anaplastic astrocytoma, oligoastrocytoma and oligodendroglioma; and diffuse glioma. The recommendations cover clinically relevant problems in: diagnosis and pathology, molecular markers, staging and risk assessment, treatment of newly diagnosed patients, treatment of patients with recurrent disease, personalised medicine, response evaluation plus follow-up and long-term implications.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings